v3.26.1
Stock-Based Compensation (Tables)
 6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Option Activity for Amended 2014 Plan and Related Information
The table below summarizes stock option activity under the Company's stock incentive plans and related information for the six months ended June 30, 2026. The exercise price of all options granted during the six months ended June 30, 2026 was equal to the market value of the Company’s common stock on the date of grant. As of June 30, 2026, unamortized stock-based compensation expense of approximately $2.0 million will be amortized over a weighted average period of 1.10 years. The number of shares of common stock available for future awards granted under the 2022 Plan as of June 30, 2026 was 1,427,206.
Number of SharesWeighted Average
Exercise Price
Outstanding at December 31, 20251,409,042 $9.41 
Granted471,700 1.84 
Exercised— 
Cancelled/forfeited(4,500)2.44 
Expired(332)249.60 
Outstanding at June 30, 20261,875,910 $7.48 
Exercisable at June 30, 2026999,416 $11.54 
Schedule of Recognized Stock-Based Compensation Expense Related to Stock Options Granted to Employees and Directors
Total stock-based compensation expense related to stock options granted to employees and non-employee directors recognized in the condensed consolidated statements of operations and comprehensive loss is as follows:
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Research and development$118,493 $158,154 $340,100 $325,212 
Selling, general and administrative$168,109 $200,864 $401,566 $411,163 
Total$286,602 $359,018 $741,666 $736,375 
Schedule of RSU Activity
The following table summarizes RSU activity for the six months ended June 30, 2026:
Number of RSUsWeighted-Average Grant-Date Fair Value
Unvested at January 1, 2026— — 
Granted145,969 $2.11 
Vested— — 
Forfeited— — 
Unvested at June 30, 2026145,969 $2.11